Zobrazeno 1 - 10
of 962
pro vyhledávání: '"Mamas A. Mamas"'
Autor:
Marlon V. Gatuz, Rami Abu-Fanne, Dmitry Abramov, Maguli Barel, Mamas A. Mamas, Ariel Roguin, Ofer Kobo
Publikováno v:
American Heart Journal Plus, Vol 46, Iss , Pp 100452- (2024)
Background: Cardiogenic shock (CS) is the leading cause of mortality in acute myocardial infarction (AMI) patients, especially in those with vascular disease. This study aimed to assess the association between extent of polyvascular disease and the i
Externí odkaz:
https://doaj.org/article/e764519cfb6f4dfd993411b1f04ccadc
Autor:
Rachel Sze Jen Goh, Bryan Chong, Jayanth Jayabaskaran, Silingga Metta Jauhari, Siew Pang Chan, Martin Tze Wah Kueh, Kannan Shankar, Henry Li, Yip Han Chin, Gwyneth Kong, Vickram Vijay Anand, Keith Andrew Chan, Indah Sukmawati, Sue Anne Toh, Mark Muthiah, Jiong-Wei Wang, Gary Tse, Anurag Mehta, Alan Fong, Lohendran Baskaran, Liang Zhong, Jonathan Yap, Khung Keong Yeo, Derek J. Hausenloy, Jack Wei Chieh Tan, Tze-Fan Chao, Yi-Heng Li, Shir Lynn Lim, Koo Hui Chan, Poay Huan Loh, Ping Chai, Tiong Cheng Yeo, Adrian F. Low, Chi Hang Lee, Roger Foo, Huay Cheem Tan, James Yip, Sarita Rao, Satoshi Honda, Satoshi Yasuda, Takashi Kajiya, Shinya Goto, Bryan P. Yan, Xin Zhou, Gemma A. Figtree, Mamas A. Mamas, Yongcheol Kim, Young-Hoon Jeong, Moo Hyun Kim, Duk-Woo Park, Seung-Jung Park, A Mark Richards, Mark Y. Chan, Gregory Y.H. Lip, Nicholas W.S. Chew
Publikováno v:
The Lancet Regional Health. Western Pacific, Vol 49, Iss , Pp 101138- (2024)
Summary: Background: Given the rapidly growing burden of cardiovascular disease (CVD) in Asia, this study forecasts the CVD burden and associated risk factors in Asia from 2025 to 2050. Methods: Data from the Global Burden of Disease 2019 study was u
Externí odkaz:
https://doaj.org/article/29d35691046b4033a58936d0dff81628
Autor:
Ellen Boakye, MD, MPH, Chigolum P. Oyeka, MD, MPH, Yaa A. Kwapong, MD, MPH, Faith E. Metlock, BSN, Sadiya S. Khan, MD, MSc, Mamas A. Mamas, MBBCh, Amanda M. Perak, MD, MS, Pamela S. Douglas, MD, Michael C. Honigberg, MD, MPP, Khurram Nasir, MD, MPH, MSc, Michael J. Blaha, MD, MPH, Garima Sharma, MD
Publikováno v:
AJPM Focus, Vol 3, Iss 4, Pp 100210- (2024)
Introduction: Suboptimal cardiovascular health is associated with adverse pregnancy outcomes and long-term cardiovascular risk. The authors examined trends in cardiovascular risk factors and correlates of suboptimal cardiovascular risk profiles among
Externí odkaz:
https://doaj.org/article/52ea2282c2974cd098362856bafe4ede
Autor:
Mohamed Hamed, Sheref Mohamed, Mohamed Mahmoud, Jonathan Kahan, Amr Mohsen, Faisal Rahman, Waleed Kayani, Fernando Alfonso, Emmanuel S. Brilakis, Islam Y. Elgendy, Mamas A. Mamas, Ayman Elbadawi
Publikováno v:
Cardiology and Therapy, Vol 13, Iss 2, Pp 379-399 (2024)
Abstract Introduction Trials evaluating the role of intravascular imaging in percutaneous coronary intervention (PCI) for complex coronary artery disease have yielded mixed results. This study aimed to compare the outcomes of intravascular imaging sp
Externí odkaz:
https://doaj.org/article/c973c686e51a4288ab07d395a95dff7d
Autor:
Ben Walters, MBChB, India Midwinter, BSc, MBBS, Carolyn A. Chew-Graham, MBChB, MD, Kelvin P. Jordan, PhD, Garima Sharma, MB, Lucy C. Chappell, MB, BCh, PhD, Emma J. Crosbie, MBChB, PhD, Purvi Parwani, MBBS, MPH, Mamas A. Mamas, BM BCh, DPhil, Pensée Wu, MBChB, MD(Res)
Publikováno v:
Mayo Clinic Proceedings: Innovations, Quality & Outcomes, Vol 8, Iss 2, Pp 188-199 (2024)
This study aimed to systematically evaluate and quantify the risk of adverse maternal and neonatal outcomes in patients with pregnancy-associated cancer (PAC). This study was conducted from February 13, 2021, through July 24, 2023. A systematic searc
Externí odkaz:
https://doaj.org/article/8bc42a0d86a3458a8a78d7ff9fde62d3
Autor:
Aida Zaheer, Feng Qiu, Ragavie Manoragavan, Mina Madan, Maneesh Sud, Mamas A. Mamas, Harindra C. Wijeysundera
Publikováno v:
Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, Vol 13, Iss 12 (2024)
Background Transcatheter aortic valve replacement (TAVR) has become the standard of care for severe aortic stenosis treatment. Exponential growth in demand has led to prolonged wait times and adverse patient outcomes. Social marginalization may contr
Externí odkaz:
https://doaj.org/article/253d2bf95def4181b96b2b7fe83edea0
Publikováno v:
American Journal of Preventive Cardiology, Vol 18, Iss , Pp 100685- (2024)
Background: The American Heart Association's (AHA) Life's Essential 8 (LE8) score is a helpful tool to quantify cardiovascular health (CVH) metrics. We sought to assess sex differences in relation to LE8 and its components along with association with
Externí odkaz:
https://doaj.org/article/bc4b0e7b95984f3c87ad98ec224d16c2
Publikováno v:
International Journal of Cardiology. Cardiovascular Risk and Prevention, Vol 21, Iss , Pp 200248- (2024)
Background: During the covid-19 pandemic there was a marked rise in the number of cardiovascular deaths. Obesity is a well-known modifiable risk factor for cardiovascular disease and has been identified as a factor which leads to poorer covid-19 rela
Externí odkaz:
https://doaj.org/article/be4ed8a4f33540ea958146c7573aaea2
Autor:
Bovey Wu, Ahmed Kheiwa, Pooja Swamy, Mamas A. Mamas, Ryan J. Tedford, Mirvat Alasnag, Purvi Parwani, Dmitry Abramov
Publikováno v:
Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, Vol 13, Iss 9 (2024)
Coronary dominance describes the anatomic variation of coronary arterial supply, notably as it relates to perfusion of the inferior cardiac territories. Differences in the development and outcome in select disease states between coronary dominance pa
Externí odkaz:
https://doaj.org/article/c82178a82a074d9485803f5eeb7d0e83
Autor:
Mohamed O. Mohamed, Evangelos Kontopantelis, Mirvat Alasnag, Leila Abid, Amitava Banerjee, Andrew S. P. Sharp, Christos Bourantas, Alex Sirker, Nick Curzen, Mamas A. Mamas
Publikováno v:
Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, Vol 13, Iss 9 (2024)
Background Over the past decade, major society guidelines have recommended the use of newer P2Y12 inhibitors over clopidogrel for those undergoing percutaneous coronary intervention for acute coronary syndrome. It is unclear what impact these recomme
Externí odkaz:
https://doaj.org/article/f39f0448b1b44a51a77a5f0d6bf943a7